Novo Nordisk A/S News Headlines

NVO 
$48.41
*  
0.62
1.26%
Get NVO Alerts
*Delayed - data as of Sep. 19, 2014  -  Find a broker to begin trading NVO now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

3 Best Stocks to Invest in Pharma
9/19/2014 9:13:02 AM - Motley Fool

Sector Update: Health-Care Shares Lower in Pre-Market Trade
9/19/2014 8:11:05 AM - MT Newswires

Sector Update: Health Care
9/19/2014 8:10:39 AM - MT Newswires

Pre-Market Most Active for Sep 18, 2014 : RAD, NOK, VVUS, SAN, MT, NVO, YHOO, AAPL, TKAI, SNE, EMKR, ERIC
9/18/2014 8:39:58 AM - NASDAQ.com News

Novo Nordisk's Tresiba Effective in Children & Adolescents - Analyst Blog
9/17/2014 6:10:00 PM - Zacks.com

Sanofi: Stiff Competition Will Impact Future Performance
9/17/2014 12:01:00 PM - Seeking Alpha

Orexigen Therapeutics Wins Contrave Approval But Investors Should Stay Away
9/16/2014 2:01:00 PM - Seeking Alpha

New Diabetes Drugs Gain Approval - Florins Versus Oral Insulin
9/14/2014 2:15:00 PM - Seeking Alpha

2 New Diet Drugs Coming Soon?
9/13/2014 2:05:03 PM - Motley Fool

Novo Gets Positive Vote From FDA For Anti-Obesity Treatment - Still A Long Road Ahead
9/12/2014 5:18:00 PM - Seeking Alpha

Novo Nordisk's Saxenda Gets Positive Opinion for Obesity - Analyst Blog
9/12/2014 5:10:00 PM - Zacks.com

Sector Update: Health Care Stocks Falling; Novo Nordisk Rising After FDA Advisory Panel Gives Nod to New Obesity Drug
9/12/2014 1:22:56 PM - MT Newswires

Sector Update: Health Care
9/12/2014 1:17:33 PM - MT Newswires

European Stocks Mixed Amid Fed Rate Hike Chatter
9/12/2014 11:56:00 AM - RTT News

Surprising New Competitor: Should Arena Pharmaceuticals, Inc. and Orexigen Therapeutics, Inc. Be Afr
9/12/2014 9:09:40 AM - Motley Fool

European Markets Mostly Lower, Aveva Plunges
9/12/2014 7:05:00 AM - RTT News

U.S. FDA Panel Urges Approval Of Novo Nordisk Injection For Obesity
9/12/2014 2:08:00 AM - RTT News

After Apple: Tech's Takeover of Healthcare Officially Begins
9/10/2014 8:21:02 PM - Motley Fool

Arena Pharmaceuticals - A Biotech Value Investment
9/10/2014 4:49:00 PM - Seeking Alpha

3 Reasons MannKind Corporation's Stock Could Fall
9/9/2014 10:42:02 AM - Motley Fool

7 States Where Diabetes Prevalence Is the Highest
9/6/2014 1:14:02 PM - Motley Fool

Novo Nordisk Drops Anti-Inflammatory R&D Activities - Analyst Blog
9/3/2014 6:20:00 PM - Zacks.com

Booming Biotech Market Benefits REIT BioMed Realty
9/2/2014 5:42:00 PM - Investor's Business Daily

Novo Nordisk's Ryzodeg Now in Mexico for Type II Diabetes - Analyst Blog
9/2/2014 3:00:00 PM - Zacks.com

Pre-Market Most Active for Sep 2, 2014 : AAPL, CPWR, CONN, SYT, FDO, CNHI, QQQ, YHOO, ACHN, TMUS, BAC, NVO
9/2/2014 8:39:55 AM - NASDAQ.com News